Education
About Us
Working with TipRanks
Follow Us
Advanced Medical Solutions (GB:AMS)
:AMS
RESEARCH TOOLSreports
AMS Stock Chart & Stats
Day’s Range― - ―
52-Week Range168.40p - 275.83p
Previous CloseN/A
Volume14.34K
Average Volume (3M)889.85K
Market Cap
£415.48M
Enterprise ValueN/A
Total Cash (Recent Filing)£134.94M
Total Debt (Recent Filing)£89.87M
Price to Earnings (P/E)58.5
Beta1.36
Next Earnings
Sep 17, 2025EPS Estimate
5.1Next Dividend Ex-Date
Jun 19, 2025Dividend Yield1.25%
Share Statistics
EPS (TTM)0.03
Shares Outstanding218,107,620
10 Day Avg. Volume665,853
30 Day Avg. Volume889,849
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£273.33Price Target Upside40.31% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
---
Advanced Medical Solutions News
PremiumCompany Announcements
Advanced Medical Solutions Directors Increase Shareholdings
PremiumCompany Announcements
Advanced Medical Solutions Grants New Share Options to Directors
PremiumCompany Announcements
Advanced Medical Solutions Announces Share Capital Details
PremiumCompany Announcements
AMS Confirms Montagu’s Decision Against Acquisition Offer
PremiumCompany Announcements
Advanced Medical Solutions Announces Share Capital Details
PremiumCompany Announcements
Advanced Medical Solutions Strengthens Board with New AppointmentPremiumCompany Announcements
Advanced Medical Solutions Faces Potential Takeover Bid from Montagu---
Bulls Say, Bears Say
Bulls Say
RevenuesRevenues increased 41% to £177.5m, boosted by the acquisitions of Peters Surgical and Syntacoll, with organic reported revenue growth of 7%.
Strategic InvestmentsStrategic investment and ongoing integration of Peters are expected to realise deal synergies and start to deliver margin expansion.
ValuationRecent share price weakness sees the company trading at approximately a 15% discount to its MedTech peers.
Bears Say
Gross Margin DeclineAdjusted group gross margin declined 250bps to 53.1%, due to adverse mix in Woundcare, dilution from lower margins for Syntacoll and Peters, and lower royalty income.
Operational PerformanceThe trading update has limited further detail on operational performance.
Revenue DeclineWoundcare saw an 11% decline in revenues with an operating margin of just 6%.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.93% Insiders
0.60%
Mutual Funds
― Other Institutional Investors
96.31% Public Companies and
Individual Investors
AMS FAQ
What was Advanced Medical Solutions’s price range in the past 12 months?
Advanced Medical Solutions lowest share price was 168.40p and its highest was 275.83p in the past 12 months.
What is Advanced Medical Solutions’s market cap?
Advanced Medical Solutions’s market cap is £415.48M.
When is Advanced Medical Solutions’s upcoming earnings report date?
Advanced Medical Solutions’s upcoming earnings report date is Sep 17, 2025 which is in 123 days.
How were Advanced Medical Solutions’s earnings last quarter?
Advanced Medical Solutions released its earnings results on Mar 19, 2025. The company reported 0.013p earnings per share for the quarter, missing the consensus estimate of 0.051p by -0.038p.
Is Advanced Medical Solutions overvalued?
According to Wall Street analysts Advanced Medical Solutions’s price is currently Undervalued.
Does Advanced Medical Solutions pay dividends?
Advanced Medical Solutions pays a Annually dividend of 2.428p which represents an annual dividend yield of 1.25%. See more information on Advanced Medical Solutions dividends here
What is Advanced Medical Solutions’s EPS estimate?
Advanced Medical Solutions’s EPS estimate is 5.1.
How many shares outstanding does Advanced Medical Solutions have?
Advanced Medical Solutions has 218,107,620 shares outstanding.
What happened to Advanced Medical Solutions’s price movement after its last earnings report?
Advanced Medical Solutions reported an EPS of 0.013p in its last earnings report, missing expectations of 0.051p. Following the earnings report the stock price went down -4.46%.
Which hedge fund is a major shareholder of Advanced Medical Solutions?
Currently, no hedge funds are holding shares in GB:AMS
---
Advanced Medical Solutions Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
£273.33 (40.31% Upside)
£273.33 (40.31% Upside)
Insider Transactions
Sold Shares
Worth £826.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.98%
12-Months-Change
Fundamentals
Return on Equity
2.95%
Trailing 12-Months
Asset Growth
34.52%
Trailing 12-Months
Company Description
Advanced Medical Solutions
Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and laparoscopic device used to fix hernia meshes placed inside the body under the LiquiBand Fix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products under the ActivHeal brand. Advanced Medical Solutions Group plc was incorporated in 1991 and is headquartered in Winsford, the United Kingdom.
---
AMS Stock 12 Month Forecast
Average Price Target
273.33p
▲(40.31% Upside)
Technical Analysis
---